Suchergebnisse - "Roque, Dana M"

PubPharm (85)

1

Correction : Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

enthalten in: British journal of cancer | 2024

von Roque, D. | Siegel, E. | Buza, N. | +18

ErratumFor: Br J Cancer. 2022 Jun;126(12):1695-1703. - PMID 35149854

2

Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids

enthalten in: Cell & bioscience | 2024

von Sorrin, A. | Dasgupta, A. | McNaughton, K. | +5

3

Co-Packaged PARP inhibitor and photosensitizer for targeted photo-chemotherapy of 3D ovarian cancer spheroids

enthalten in: Cell & bioscience | 2024

von Sorrin, A. | Dasgupta, A. | McNaughton, K. | +5

4

Early Implementation of Robotic Training in Surgical and Surgical Subspecialty Residency

enthalten in: The American surgeon | 2024

von Newland, J. | Sundel, M. | Blackburn, K. | +6

5

Fluorescence-guided photoimmunotherapy using targeted nanotechnology and ML7710 to manage peritoneal carcinomatosis

enthalten in: Science advances | 2023

von Liang, B. | Pang, S. | Perttila, R. | +11

6

Transient fluid flow improves photoimmunoconjugate delivery and photoimmunotherapy efficacy

enthalten in: iScience | 2023

von Sorrin, A. | Zhou, K. | May, K. | +7

7

Clinical Outcomes of Intensity Modulated Proton Therapy Reirradiation for Gynecologic Malignancies

enthalten in: Advances in radiation oncology | 2023

von Pollock, A. | Risher, H. | Berger, M. | +4

8

In vitro fertilization : a cross-sectional analysis of 58 US insurance companies

enthalten in: Journal of assisted reproduction and genetics | 2023

von Ha, M. | Drees, A. | Myers, M. | +7

CommentIn: J Assist Reprod Genet. 2023 Mar;40(3):577-580. - PMID 36856969

9

Pap smear outcomes in elderly women living with HIV and HIV-negative matched controls

enthalten in: International journal of STD & AIDS | 2022

von Klein, K. | Goron, A. | Taylor, G. | +1

10

Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu

enthalten in: Gynecologic oncology | 2022

von Yadav, G. | Roque, D. | Bellone, S. | +18

1
2
3
4
5
6
7
8
9
Nächster »
[9]